BIOMARKER:

TSC2 mutation

Entrez ID:

Related biomarkers:

‹

›

TSC2 mutation TSC2 mutation	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	TSC2 mutation TSC2 mutation	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	copanlisib Sensitive: C3 – Early Trials	copanlisib Sensitive: C3 – Early Trials
TSC2 mutation TSC2 mutation	Endometrial Cancer Endometrial Cancer	TSC2 mutation TSC2 mutation	Endometrial Cancer Endometrial Cancer	temsirolimus Sensitive: C3 – Early Trials	temsirolimus Sensitive: C3 – Early Trials
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	everolimus Sensitive: C3 – Early Trials	everolimus Sensitive: C3 – Early Trials
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	temsirolimus Sensitive: C3 – Early Trials	temsirolimus Sensitive: C3 – Early Trials
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	mTOR inhibitor Sensitive: C3 – Early Trials	mTOR inhibitor Sensitive: C3 – Early Trials
TSC2 mutation TSC2 mutation	Pancreatic Cancer Pancreatic Cancer	TSC2 mutation TSC2 mutation	Pancreatic Cancer Pancreatic Cancer	Immunotherapy Sensitive: C4 – Case Studies	Immunotherapy Sensitive: C4 – Case Studies